Safety and feasibility of curved lead simultaneously implanted into pedunculopontine nucleus and subthalamic nucleus  

作　　者：Wei Wang Xiaoyong Chen Deyuan Chen Yue Chen Lianghong Yu Yuanxiang Lin Dezhi Kang Xiangrong Chen Chenyu Ding 

机构地区：[1]Department of Neurosurgery,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325000,China [2]Department of Neurosurgery,Neurosurgical Research Institute,The First Affiliated Hospital,Fujian Medical University,Fuzhou,Fujian 350005,China [3]Department of Pathology,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325000,China [4]Department of Neurosurgery,The Second Affiliated Hospital of Fujian Medical University,Quanzhou,Fujian 362000,China

出　　处：《Chinese Medical Journal》2022年第20期2509-2511,共3页中华医学杂志（英文版）

基　　金：National Natural Science Foundation of China(No. 81901395)

摘　　要：To the Editor:Combined nuclei stimulation may have a synergistic effect on controlling the symptoms of nervous system diseases and improving quality of life.[1]However,increasing of leads may increase costs and complications.[2]Therefore,our study aims to investigate the safety and feasibility of the single curved lead,which can simultaneously reach both subthalamic nucleus(STN)and pedunculopontine nucleus(PPN).

关 键 词：curved SIMULTANEOUS SYNERGISTIC 

分 类 号：R651.1[医药卫生—外科学]